Medline accuses competitor of confusing customers over COVID-19 PPE
A manufacturer of healthcare products including personal protective equipment (PPE) has accused a newly incorporated company of trying to confuse consumers during the COVID-19 pandemic.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.
29 April 2020 3M has filed another trademark infringement suit against what it’s called a “deplorable pandemic profiteer”, as the multinational seeks to stop the alleged price-gouging of N95 masks amid the COVID-19 outbreak.
29 April 2020 3M has filed another trademark infringement suit against what it’s called a “deplorable pandemic profiteer”, as the multinational seeks to stop the alleged price-gouging of N95 masks amid the COVID-19 outbreak.
12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.
29 April 2020 3M has filed another trademark infringement suit against what it’s called a “deplorable pandemic profiteer”, as the multinational seeks to stop the alleged price-gouging of N95 masks amid the COVID-19 outbreak.
12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.